Buy or sell Codiak Biosciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Codiak Biosciences Stock

Biotechnology

Founded

2015

Notable Investors

Flagship Pioneering

Headquarters

San Francisco CA, US

Total Funding

$174M

About Codiak Biosciences Stock

Codiak Biosciences is developing exosomes, natural vesicles that mediate inter-cellular communication, as both a powerful therapeutic modality and an advanced diagnostic system. Codiak is building a world-class team and has generated and acquired foundational intellectual property that will allow it to capitalize on the unique potential of exosome biology.

Investors

Alaska Permanent Fund

Indigo, Codiak Biosciences

Alexandria Venture Investments

Codiak Biosciences

Boxer Capital

Codiak Biosciences

EcoR1 Capital

Codiak Biosciences

Qatar Investment Authority

SoFi, D2iQ, Codiak Biosciences

Sirona Capital

Codiak Biosciences

Yukon Partners

Codiak Biosciences

Funding History

November 2015$33.2M
November 2015$64.2M
November 2017$76.5M

Management

Chief Executive Officer

Doug Williams

Chief Business Officer

Richard Brudnick

Chief Financial Officer

Linda C. Bain

Scientific Co-Founder

Raghu Kalluri

Scientific Co-Founder

Eric Lander

Chief Scientist

Jan Lötvall

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Codiak Biosciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo